{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T17:21:55Z","timestamp":1713979315447},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,4,22]],"date-time":"2024-04-22T00:00:00Z","timestamp":1713744000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,4,22]],"date-time":"2024-04-22T00:00:00Z","timestamp":1713744000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>To present an unusual case of abnormal LCA expression and CD43 in SCLC and to review the reported literature to avoid potential diagnostic pitfalls.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>A 73-year-old male patient suffered from persistent back pain for more than one month. MRI revealed a compression fracture of the L1-L5 vertebra. A CT scan revealed multiple nodules and masses at the left root of the neck, lung hilum and mediastinum, and multiple areas of bony destruction of the ribs. Histology of the tumor revealed that small and round cells were arranged in nests with areas of necrosis. The tumor cells were round to ovoid with scant cytoplasm and indistinct cell borders. The nuclear chromatin was finely granular, and the nucleoli were absent or inconspicuous. Immunohistochemically, the tumor cells were positive for cytokeratin, TTF-1, POU2F3, LCA, and CD43.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>This report highlights a potential diagnostic pitfall in the diagnosis of SCLC, urges pathologists to exercise caution in cases of LCA and CD43 positivity and illustrates the need for further immunohistochemical studies to avoid misdiagnosis.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12890-024-03005-w","type":"journal-article","created":{"date-parts":[[2024,4,22]],"date-time":"2024-04-22T12:02:14Z","timestamp":1713787334000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Abnormal expression of LCA and CD43 in SCLC: a rare case report and brief literature review"],"prefix":"10.1186","volume":"24","author":[{"given":"Zhe","family":"Cai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linwei","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fangfang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huiyan","family":"You","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangtong","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shousheng","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fanrong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lixiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenyong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,4,22]]},"reference":[{"key":"3005_CR1","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.imlet.2018.01.009","volume":"196","author":"A Rheinl\u00e4nder","year":"2018","unstructured":"Rheinl\u00e4nder A, Schraven B. U Bommhardt CD45 in human physiology and clinical medicine. Immunol Lett. 2018;196:22\u201332.","journal-title":"Immunol Lett"},{"key":"3005_CR2","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1097\/PAI.0b013e318031c265","volume":"15","author":"MA Houreih","year":"2007","unstructured":"Houreih MA, Eyden BP, Reeve N, et al. Aberrant leukocyte common antigen expression in metastatic small cell lung carcinoma: a rare finding and a potential diagnostic pitfall. Appl Immunohistochem Mol Morphol. 2007;15:236\u201338.","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"3005_CR3","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1002\/1097-0142(19870415)59:8<1438::AID-CNCR2820590809>3.0.CO;2-K","volume":"59","author":"JM McDonnell","year":"1987","unstructured":"McDonnell JM, Beschorner WE, Kuhajda FP, et al. Common leukocyte antigen staining of a primitive sarcoma. Cancer. 1987;59:1438\u201341.","journal-title":"Cancer"},{"issue":"12","key":"3005_CR4","first-page":"1204","volume":"11","author":"MA Nandedkar","year":"1998","unstructured":"Nandedkar MA, Palazzo J, Abbondanzo SL, et al. CD45 (leukocyte common antigen) immunoreactivity in metastatic undifferentiated and neuroendocrine carcinoma: a potential diagnostic pitfall. Mod Pathol. 1998;11(12):1204\u201310.","journal-title":"Mod Pathol"},{"issue":"2","key":"3005_CR5","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1097\/PAI.0b013e318036bf8c","volume":"16","author":"RR Seethala","year":"2008","unstructured":"Seethala RR, Pasha TL, Raghunath PN, et al. The selective expression of CD43 in adenoid cystic carcinoma. Appl Immunohistochem Mol Morphol. 2008;16(2):165\u201372.","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"3005_CR6","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1093\/ajcp\/110.5.641","volume":"110","author":"AR Judkins","year":"1998","unstructured":"Judkins AR, Montone KT, LiVolsi VA, et al. Sensitivity and specificity of antibodies on necrotic tumor tissue. Am J Clin Pathol. 1998;110:641\u20136.","journal-title":"Am J Clin Pathol"},{"key":"3005_CR7","first-page":"130","volume":"23","author":"N Cartagena Jr","year":"1993","unstructured":"Cartagena N Jr, Suster S, Cabello-Inchausti B. Artifactual distortion of cells simulating metastatic small cell carcinoma in the bone marrow. Ann Clin Lab Sci. 1993;23:130\u20136.","journal-title":"Ann Clin Lab Sci"},{"issue":"8","key":"3005_CR8","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1002\/ijc.27873","volume":"132","author":"Q Fu","year":"2013","unstructured":"Fu Q, Cash SE, Andersen JJ, et al. CD43 in the nucleus and cytoplasm of lung cancer is a potential therapeutic target. Int J Cancer. 2013;132(8):1761\u201370.","journal-title":"Int J Cancer"},{"key":"3005_CR9","first-page":"1413","volume":"138","author":"C Gustmann","year":"1991","unstructured":"Gustmann C, Altmannsberger M, Osborn M, et al. Cytokeratin expression and vimentin content in large cell anaplastic lymphomas and other non-hodgkin\u2019s lymphomas. Am J Pathol. 1991;138:1413\u201322.","journal-title":"Am J Pathol"},{"key":"3005_CR10","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1097\/00000478-199603000-00012","volume":"20","author":"J Lasota","year":"1996","unstructured":"Lasota J, Hyjek E, Koo CH, et al. Cytokeratin-positive large-cell lymphomas of B-cell lineage. A study of five phenotypically unusual cases verified by polymerase chain reaction. Am J Surg Pathol. 1996;20:346\u201354.","journal-title":"Am J Surg Pathol"},{"issue":"12","key":"3005_CR11","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1016\/j.jtho.2020.09.009","volume":"15","author":"MK Baine","year":"2020","unstructured":"Baine MK, Hsieh MS, Lai WV, et al. SCLC subtypes defined by ASCL1, NEUROD1, POU2F3, and YAP1: a comprehensive immunohistochemical and histopathologic characterization. J Thorac Oncol. 2020;15(12):1823\u201335.","journal-title":"J Thorac Oncol"},{"issue":"1","key":"3005_CR12","doi-asserted-by":"publisher","first-page":"3372","DOI":"10.1038\/s41467-021-23780-y","volume":"12","author":"NJ Brady","year":"2021","unstructured":"Brady NJ, Bagadion AM, Singh R, et al. Temporal evolution of cellular heterogeneity during the progression to advanced AR-negative prostate cancer. Nat Commun. 2021;12(1):3372.","journal-title":"Nat Commun"},{"issue":"9","key":"3005_CR13","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/j.jtho.2022.06.004","volume":"17","author":"MK Baine","year":"2022","unstructured":"Baine MK, Febres-Aldana CA, Chang JC, et al. POU2F3 in SCLC: Clinicopathologic and genomic analysis with a focus on its diagnostic utility in Neuroendocrine-Low SCLC. J Thorac Oncol. 2022;17(9):1109\u201321.","journal-title":"J Thorac Oncol"},{"issue":"13\u201314","key":"3005_CR14","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1101\/gad.314815.118","volume":"32","author":"YH Huang","year":"2018","unstructured":"Huang YH, Klingbeil O, He XY, et al. POU2F3 is a master regulator of a tuft cell-like variant of small cell lung cancer. Genes Dev. 2018;32(13\u201314):915\u201328.","journal-title":"Genes Dev"},{"issue":"2","key":"3005_CR15","first-page":"LMT13","volume":"8","author":"A Dmitriy Sonkin","year":"2019","unstructured":"Dmitriy Sonkin A, Thomas. Beverly A Teicher.Are neuroendocrine negative small cell lung cancer and large cell neuroendocrine carcinoma with WT RB1 two faces of the same entity?Lung. Cancer Manag. 2019;8(2):LMT13.","journal-title":"Cancer Manag"},{"key":"3005_CR16","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1016\/j.jtho.2022.07.001","volume":"17","author":"H Ryota Matsuoka","year":"2022","unstructured":"Ryota Matsuoka H, Kawai T, Ito D, Matsubara. Determining whether YAP1 and POU2F3 are antineuroendocrine factors. J Thorac Oncol. 2022;17:1070\u20133.","journal-title":"J Thorac Oncol"},{"key":"3005_CR17","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1016\/j.jtho.2020.09.009","volume":"15","author":"K Marina","year":"2020","unstructured":"Marina K, Baine M-S, Hsieh W, Victoria Lai JV, Egger AA, Jungbluth Y, Daneshbod A, Beras R, Spencer J, Lopardo F, Bodd J, Montecalvo JL, Sauter, Jason C, Chang, Darren J, Buonocore, William D, Travis T, Sen JT, Poirier CM, Rudin. Natasha Rekhtman. SCLC subtypes defined by ASCL1, NEUROD1, POU2F3, and YAP1: a comprehensive immunohistochemical and histopathologic characterization. J Thorac Oncol. 2020;15:1823\u201335.","journal-title":"J Thorac Oncol"},{"key":"3005_CR18","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/s41379-021-00943-2","volume":"35","author":"N Rekhtman","year":"2022","unstructured":"Rekhtman N. Lung neuroendocrine neoplasms: recent progress and persistent challenges. Mod Pathol. 2022;35:36\u201350.","journal-title":"Mod Pathol"},{"issue":"8","key":"3005_CR19","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1111\/1759-7714.14382","volume":"13","author":"S Matsui","year":"2022","unstructured":"Matsui S, Haruki T, Oshima Y, et al. High mRNA expression of POU2F3 in small cell lung cancer cell lines predicts the effect of lurbinectedin. Thorac Cancer. 2022;13(8):1184\u201392.","journal-title":"Thorac Cancer"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-024-03005-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12890-024-03005-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-024-03005-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,22]],"date-time":"2024-04-22T12:02:19Z","timestamp":1713787339000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpulmmed.biomedcentral.com\/articles\/10.1186\/s12890-024-03005-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,22]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3005"],"URL":"https:\/\/doi.org\/10.1186\/s12890-024-03005-w","relation":{},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,22]]},"assertion":[{"value":"28 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This publication was approved by the Ethics Committee of the Second Affiliated Hospital of Nanchang University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Informed consent for the publication of this study was obtained from the patients\u2019 next-to-kin and written informed consent to publish this information was obtained.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors disclose no conflicts.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"195"}}